Tarsus Pharmaceuticals, Inc. ( (TARS) ) has released its Q3 earnings. Here is a breakdown of the information Tarsus Pharmaceuticals, Inc.

Announced Exclusive Licensing Agreement with Viatris for Sotagliflozin in all Markets Outside of the U.S. and EuropeCompleted ZYNQUISTA™ FDA ...

States may be getting ready to crack down even harder on pharmacy benefit managers ... One NAIC panel, the Regulatory Framework Task Force, plans to hear a presentation on PBM transparency initiatives ...

Those ever-present TV drug ads showing patients hiking, biking or enjoying a day at the beach could soon have a different ...

Welcome to the GoodRx third-quarter 2024 earnings call. As a reminder, today's conference call is being recorded. I would now ...

The 80's and 90's spawned a host of selling models and most of us in the pharma business have been ... have risen to become the dominant force in a cash strapped world. The influence of patients ...

Presentation Operator Hello, and welcome to the Mettler-Toledo Third Quarter 2024 Earnings Call. [Operator Instructions] I ...

The "North America RNA Therapeutics Market, By Country, Competition, Forecast & Opportunities, 2019-2029F" report has been ...

Pharma-specific data on changing customer preferences Customer landscape and pharma field force touchpoints Ensuring field force engagements are customer-centric Providing relevant messaging to ...

Infinity Pharmaceuticals Inc. 0.00% $90.76 ...

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people worldwide every day. Reuters provides business, financial ...

IPC Indice de Precios Y Cotizaciones 51,096.64-352.79-0.69% ...